Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia
Condition(s):Cicatricial AlopeciaLast Updated:October 10, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Cicatricial AlopeciaLast Updated:October 10, 2023Completed
Condition(s):Cicatricial AlopeciaLast Updated:August 14, 2023Recruiting
Condition(s):Central Centrifugal Cicatricial AlopeciaLast Updated:May 9, 2022Completed
Condition(s):Central Centrifugal Cicatricial AlopeciaLast Updated:January 3, 2024Recruiting
Condition(s):Central Centrifugal Cicatricial AlopeciaLast Updated:January 3, 2024Not yet recruiting
Condition(s):Central Centrifugal Cicatricial AlopeciaLast Updated:August 31, 2023Withdrawn
Condition(s):Central Centrifugal Cicatricial AlopeciaLast Updated:November 1, 2023Recruiting
Condition(s):Central Centrifugal Cicatricial Alopecia (CCCA)Last Updated:January 30, 2024Recruiting
Condition(s):Scarring Alopecia; Androgenetic AlopeciaLast Updated:December 12, 2023Recruiting
Condition(s):Central Centrifugal Scarring Alopecia; Lichen Planopilaris; Discoid Lupus ErythematosusLast Updated:July 6, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.